Clinical-scale elutriation as a means of enriching antigen-presenting cells and manipulating alloreactivity

Cytotherapy

Volumn 11, Issue 2, 2009, Pages 218-228

  Micklethwaite, Kenneth P ^a   Garvin, Frances M ^b   Kariotis, Melina R ^b   Yee, Leng L ^b   Hansen, Anna M ^b   Antonenas, Vicki ^b   Sartor, Mary ^b   Turtle, Cameron J ^b   Gottlieb, David J ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

Blood dendritic cells; Effector memory T cells; Elutra ; Elutriation; Monocytes

Indexed keywords

ALLOIMMUNITY; ANTIGEN PRESENTING CELL; APHERESIS; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL COUNT; CELL FRACTIONATION; CELL ISOLATION; CELL MANIPULATION; CELL SELECTION; CONTROLLED STUDY; DENDRITIC CELL; EFFECTOR CELL; ELUTRIATION; ENRICHMENT CULTURE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOLOGICAL TECHNIQUE; IMMUNOMAGNETIC SEPARATION; IMMUNOPHENOTYPING; INTERMETHOD COMPARISON; LYMPHOCYTE PROLIFERATION; MEMORY CELL; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGEN-PRESENTING CELLS; B-LYMPHOCYTES; BIOMEDICAL RESEARCH; CD4-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; DENDRITIC CELLS; FLOW CYTOMETRY; HUMANS; IMMUNITY, CELLULAR; IMMUNOLOGIC MEMORY; IMMUNOTHERAPY, ADOPTIVE; ISOANTIGENS; KILLER CELLS, NATURAL; L-SELECTIN; LYMPHOCYTE CULTURE TEST, MIXED; LYMPHOCYTE SUBSETS;

EID: 68049135449     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240802702160     Document Type: Article

References (32)

1. Leen AM, Myers GD, Sili U, Huls MH,Weiss H, Leung KS et al. Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals. Nat Med 2006;12(10):1160-6.
2. Saito H, Frleta D, Dubsky P, Palucka AK. Dendritic cell-based vaccination against cancer. Hematol Oncol Clin North Am 2006; 20(3):689-710.
3. Dzionek A, Fuchs A, Schmidt P, Cremer S, Zysk M, Miltenyi S et al. BDCA-2, BDCA-3, and BDCA-4: Three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol 2000;165(11):6037-46.
4. Hsu FJ, Benike C, Fagnoni F, Liles TM, Czerwinski D, Taidi B et al. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med 1996;2(1):52-8.
5. Timmerman JM, Czerwinski DK, Davis TA, Hsu FJ, Benike C, Hao ZM et al. Idiotype-pulsed dendritic cell vaccination for Bcell lymphoma: clinical and immune responses in 35 patients. Blood 2002;99(5):1517-26.
6. + progenitors and activated with type I interferon. J Immunother 2005;28(5):505-16.
7. + cells by interleukin-6 and interleukin-3. Stem Cells 2004;22(5):725-40.
8. Hsu AK, Kerr BM, Jones KL, Lock RB, Hart DN, Rice AM. RNA loading of leukemic antigens into cord blood-derived dendritic cells for immunotherapy. Biol Blood Marrow Transplant 2006;12(8):855-67.
9. Bender A, Sapp M, Schuler G, Steinman RM, Bhardwaj N. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J Immunol Methods 1996;196(2):121-35.
10. Berger TG, Strasser E, Smith R, Carste C, Schuler-Thurner B, Kaempgen E et al. Efficient elutriation of monocytes within a closed system (Elutra) for clinical-scale generation of dendritic cells. J Immunol Methods 2005;298(1-2):61-72.
11. GAMBRO.BCT. Elutra cell separation system operator's manual. For use with Elutra system version 1.1, 2005, Chapter 12. p. 2.
12. Czerniecki B, Carter C, Rivoltini L, Koski G, Kim H, Weng D et al. Calcium ionophore-treated peripheral blood monocytes and dendritic cells rapidly display characteristics of activated dendritic cells. J Immunol 1997;159(8):3823-37.
13. + T cells to tumor antigens by dendritic cells leads to enhanced functional avidity and direct tumor recognition through an IL-12-dependent mechanism. J Immunol 2003;171(5):2251-61.
14. Ossevoort MA, Toes RE, De Bruijn ML, Melief CJ, Figdor CG, Kast WM. A rapid isolation procedure for dendritic cells from mouse spleen by centrifugal elutriation. J Immunol Methods 1992; 155(1):101-11.
15. Whiteside TL, Piazza P, Reiter A, Stanson J, Connolly NC, Rinaldo CR Jr, et al. Production of DC-based vaccine containing inactivated autologous virus for therapy of patients with chronic HIV-1 infection. Clin Vaccine Immunol 2009;16(2):233-240.
16. Gulen D, Abe F, Maas S, Reed E, Cowan K, Pirruccello S et al. Closing the manufacturing process of dendritic cell vaccines transduced with adenovirus vectors. Int Immunopharmacol 2008; 8(13-14):1728-36.
17. Chen Y, Hoecker P, Zeng J, Dettke M. Combination of Cobe AutoPBSC and Gambro Elutra as a platform for monocyte enrichment in dendritic cell (DC) therapy: Clinical study. J Clin Apher 2008;23(5):157-62.
18. Perseghin P, D'Amico G, Dander E, Gaipa G, Dassi M, Biagi E et al. Isolation of monocytes from leukapheretic products for large-scale GMP-grade generation of cytomegalovirus-specificT- cell lines by means of an automated elutriation device. Transfusion 2008;48(8):1644-9.
19. Kim S, Kim HO, Baek EJ, Choi Y, Kim HS, Lee MG. Monocyte enrichment from leukapheresis products by using the Elutra cell separator. Transfusion 2007;47(12):2290-6.
20. Erdmann M, Dorrie J, Schaft N, Strasser E, Hendelmeier M, Kampgen E et al. Effective clinical-scale production of dendritic cell vaccines by monocyte elutriation directly in medium, subsequent culture in bags and final antigen loading using peptides or RNA transfection. J Immunother 2007;30(6):663-74.
21. Jarnjak-Jankovic S, Hammerstad H, Saeboe-Larssen S, Kvalheim G, Gaudernack G. A full scale comparative study of methods for generation of functional dendritic cells for use as cancer vaccines. BMC Cancer 2007;7(1):119.
22. Lemarie C, Sugaye R, Kaur I, Taga T, Chabannon C, Schuyler R et al. Purification of monocytes from cryopreserved mobilized apheresis products by elutriation with the Elutra(R) device. J Immunol Methods 2007;318(1-2):30-6.
23. ten Brinke A, Karsten ML, Dieker MC, Zwaginga JJ, Vrielink H, Marieke van Ham S. Generation of dendritic cells for immunotherapy is minimally impaired by granulocytes in the monocyte preparation. Immunobiol Eur Macro Dend Cell Soc 2006; 211(6-8):633-40.
24. Schwanke U, Nabereit A, Moog R. Isolation of monocytes from whole blood-derived buffy coats by continuous counter-flow elutriation. J Clin Apher 2006;21(3):153-7.
25. Lopez JA, Bioley G, Turtle CJ, Pinzon-Charry A, Ho CS, Vuckovic S et al. Single step enrichment of blood dendritic cells by positive immunoselection. J Immunol Methods 2003; 274(1-2):47-61.
26. Patterson S, Donaghy H, Amjadi P, Gazzard B, Gotch F, Kelleher P. Human BDCA-1-positive blood dendritic cells differentiate into phenotypically distinct immature and mature populations in the absence of exogenous maturational stimuli: Differentiation failure in HIV infection. J Immunol 2005;174(12): 8200-9.
27. Radford KJ, Turtle CJ, Kassianos AJ, Vuckovic S, Gardiner D, Khalil D et al. Immunoselection of functional CMRF-56+ blood dendritic cells from multiple myeloma patients for immunotherapy. J Immunother 2005;28(4):322-31.
28. Barrett J. Improving outcome of allogeneic stem cell transplantation by immunomodulation of the early post-transplant environment. Curr Opin Immunol 2006;18(5):592-8.
29. + Tcells do not induce graft-versus-host disease. J Clin Invest 2003;112(1):101-8.
30. + naive Tcells: Potential for adoptive immunotherapy and allodepletion. Blood 2004;104(8):2403-9.
31. - memory T cells without graft-versus-host disease. Blood 004;103(4):1534-41.
32. + T cells derived from central memory cells establishes persistent T cell memory in primates. J Clin Invest 2008;118(1):294-305.